Clinical TrialID 5658
Treatment of Multiple Sclerosis Using Over the Counter Inosine
NCT00067327
Multiple Sclerosis, Relapsing-Remitting
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5658
- Evidence Id
- 5658
- Core Evidence Id
- 5658
- Source Clinical Trial Id
- 5644
- Herb2 Clinical Trial Id
- HBCT005644
- Nct Id
- NCT00067327
- Title
- Treatment of Multiple Sclerosis Using Over the Counter Inosine
- Status
- Completed
- Phase
- Phase 2
- Study Result
- No
- Study Condition
- Multiple Sclerosis, Relapsing-Remitting
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
- Intervention
- DRUG: Inosine
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 30
- Outcome Measure
- Sponsor Collaborator
- National Center for Complementary and Integrative Health (NCCIH)
- Funded By
- NIH
- Location
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States
- Other Id
- R21AT001301-01A1
- Start Date
- 2002-02
- Primary Completion Date
- Completion Date
- 2005-09
- First Posted
- 2003-08-19
- Results First Posted
- Last Update Posted
- 2006-03-17
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00067327
- Title Cn
- Title En
- Treatment of Multiple Sclerosis Using Over the Counter Inosine
- Bilingual Status
- semi_complete